Last reviewed · How we verify

NCT06847620

Effect of Verapamil as an Adjuvant to Local Anaethetics in Supraclav Block for Hand Surgery

Completed Phase 4 Last updated 26 February 2025
What this trial tests

Phase 4 trial testing Supraclavicular Brachial Plexus Block in Hand Surgery in 32 participants. Completed in 15 October 2024.

Timeline
1 March 2024
Primary endpoint
4 September 2024
15 October 2024

Quick facts

Lead sponsorAin Shams University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment32
Start date1 March 2024
Primary completion4 September 2024
Estimated completion15 October 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 21 to 70, any sex, with Hand Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the role of verapamil when added to bupivacaine in ultrasound-giuded supraclavicular Brachial plexus block regarding the duration of action of the block, onset of action and the need of rescue analgesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hand Surgery

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06847620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing